Rituximab Equally Effective in MG Patients 65 or Older, Analysis Finds

Rituximab Equally Effective in MG Patients 65 or Older, Analysis Finds

303460

Rituximab Equally Effective in MG Patients 65 or Older, Analysis Finds

One year of rituximab therapy was effective in people with myasthenia gravis (MG) ages 65 or older, with no significant differences in response or safety seen in this older patient group relative to younger patients, an analysis of medical records found. “Rituximab should be considered in the treatment paradigm in older patients and in non-refractory [treatable] MG patients of any age,” the researchers wrote. The analysis, “Retrospective Analysis of Safety and Outcomes of Rituximab for…

You must be logged in to read/download the full post.